270 results on '"Cuneo, Kyle C."'
Search Results
2. Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer
3. Efficacy of a Second Course of Radiation for Patients With Metachronous Hepatocellular Carcinoma
4. Advances in Radiation Therapy for Primary Liver Cancer
5. Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer
6. Is Apparent Diffusion Coefficient Established as an Imaging Biomarker for Stereotactic Body Radiation Therapy Assessment in Hepatocellular Carcinoma?
7. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma
8. Intricacies of Human-AI Interaction in Dynamic Decision-Making for Precision Oncology: A Case Study in Response-Adaptive Radiotherapy
9. The Potential for Midtreatment Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation Therapy
10. Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors
11. Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease
12. PET/CT-Based Absorbed Dose Maps in 90Y Selective Internal Radiation Therapy Correlate with Spatial Changes in Liver Function Derived from Dynamic MRI.
13. Treatment of Locally Recurrent Rectal Cancer: A Review.
14. In-Depth Proteome Profiling of Small Extracellular Vesicles Isolated from Cancer Cell Lines and Patient Serum
15. Does Vascular Collapse Occur After Treatment of Hepatocellular Cancer With Stereotactic Body Radiation Therapy?
16. Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up
17. Role of Stereotactic Body Radiation Therapy in Oligometastatic Sarcoma
18. Supplementary Data 1 from A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma
19. Data from A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma
20. Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy
21. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases
22. Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy
23. A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma
24. PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer
25. Abstract CT151: A phase II study of optimized individualized adaptive radiation therapy for hepatocellular carcinoma
26. 434 Ionizing radiation acoustic imaging (iRAI) for volumetric mapping the dose deep in the liver during radiation therapy
27. Data from Histone Deacetylase (HDAC) Inhibitor LBH589 Increases Duration of γ-H2AX Foci and Confines HDAC4 to the Cytoplasm in Irradiated Non–Small Cell Lung Cancer
28. Supplementary Figures 1-2 from Histone Deacetylase (HDAC) Inhibitor LBH589 Increases Duration of γ-H2AX Foci and Confines HDAC4 to the Cytoplasm in Irradiated Non–Small Cell Lung Cancer
29. Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress
30. Stereotactic body radiation therapy (SBRT) following Yttrium-90 (90Y) selective internal radiation therapy (SIRT): a feasibility planning study using 90Y delivered dose
31. Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy
32. A human-in-the-loop based Bayesian network approach to improve imbalanced radiation outcomes prediction for hepatocellular cancer patients with stereotactic body radiotherapy
33. Sequential Method for Analysis of CTCs and Exosomes from the Same Sample of Patient Blood
34. Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology
35. Improved quantitative 90Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modeling
36. Is Apparent Diffusion Coefficient Established as an Imaging Biomarker for Stereotactic Body Radiation Therapy Assessment in Hepatocellular Carcinoma?
37. Impact of 90Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization
38. Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma
39. Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial
40. Imaging Primary Mouse Sarcomas After Radiation Therapy Using Cathepsin-Activatable Fluorescent Imaging Agents
41. Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant Gliomas
42. Factors associated with disease‐free and abdominal recurrence‐free survival in abdominopelvic and retroperitoneal sarcomas
43. Growing Evidence Supports the Use of Radiation Therapy in Unresectable Intrahepatic Cholangiocarcinoma
44. Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity
45. Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver Injury123
46. EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection
47. In Regard to Lo et al
48. Hedgehog signaling in the murine melanoma microenvironment
49. Drug–Radiotherapy Combination Trial Developments—Letter
50. TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.